Home › Juvenile Myelomonocytic Leukemia › Tennessee › Memphis
Juvenile Myelomonocytic Leukemia clinical trials in Memphis, TN
3 studies for Juvenile Myelomonocytic Leukemia are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RecruitingPhase 1/2
- St. Jude Children's Research Hospital Memphis, Memphis
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RecruitingPhase 1
- Saint Jude Children's Research Hospital, Memphis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Saint Jude Children's Research Hospital, Memphis
Juvenile Myelomonocytic Leukemia trials in other cities
- Minneapolis, MN4 studies
- Philadelphia, PA4 studies
- Boston, MA3 studies
- Atlanta, GA3 studies
- Chicago, IL3 studies
- Cincinnati, OH3 studies
- Indianapolis, IN3 studies
- Washington, DC3 studies
- Ann Arbor, MI3 studies
- New York City, NY3 studies
- San Francisco, CA3 studies
- Seattle, WA3 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer22 studies
- Lung Cancer18 studies
- Sickle Cell Disease18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Soft Tissue Sarcoma11 studies
- Melanoma11 studies
- Prostate Cancer11 studies
- Colorectal Cancer11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.